Log in

CVE:EPIESSA Pharma Stock Price, Forecast & News

C$7.52
0.00 (0.00 %)
(As of 07/10/2020 06:00 AM ET)
Add
Compare
Today's Range
C$7.52
Now: C$7.52
C$7.52
50-Day Range
C$6.40
MA: C$7.35
C$8.41
52-Week Range
C$1.90
Now: C$7.52
C$8.50
VolumeN/A
Average Volume2,198 shs
Market CapitalizationC$156.60 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.69 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-778-3310962

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$1.92 per share
Book ValueC$1.93 per share

Profitability

Miscellaneous

Employees15
Market CapC$156.60 million
Next Earnings Date8/12/2020 (Estimated)
OptionableOptionable

Receive EPI News and Ratings via Email

Sign-up to receive the latest news and ratings for EPI and its competitors with MarketBeat's FREE daily newsletter.

ESSA Pharma (CVE:EPI) Frequently Asked Questions

How has ESSA Pharma's stock been impacted by COVID-19 (Coronavirus)?

ESSA Pharma's stock was trading at C$5.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EPI stock has increased by 35.3% and is now trading at C$7.52. View which stocks have been most impacted by Coronavirus.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for ESSA Pharma.

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc (CVE:EPI) announced its earnings results on Thursday, May, 7th. The company reported ($0.60) EPS for the quarter, missing the consensus estimate of ($0.27) by $0.33. View ESSA Pharma's earnings history.

Has ESSA Pharma been receiving favorable news coverage?

Headlines about EPI stock have been trending negative on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ESSA Pharma earned a daily sentiment score of -2.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about ESSA Pharma.

Who are some of ESSA Pharma's key competitors?

What other stocks do shareholders of ESSA Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ESSA Pharma investors own include Aurora Cannabis (ACB), Athabasca Oil (ATH), ARC Resources (ARX), Aecon Group (ARE), Apricus Biosciences (APRI), Aphria (APHA), AGT Food and Ingredients (AGT), Alamos Gold (AGI), Air Canada (AC) and Advantage Oil & Gas (AAV).

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 69)
  • Mr. David S. Wood, Chief Financial Officer (Age 62)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 48)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 72)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 58)

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EPI."

How do I buy shares of ESSA Pharma?

Shares of EPI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPI stock can currently be purchased for approximately C$7.52.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of C$156.60 million. ESSA Pharma employs 15 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is essapharmaceuticals.com.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 Broadway W Suite 720, VANCOUVER, BC V5Z 1K5, Canada. The company can be reached via phone at +1-778-3310962.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.